Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Quagen promethazine codeine?

See the DrugPatentWatch profile for promethazine

What is “Quagen promethazine codeine” used for?

“Quagen promethazine codeine” refers to a brand/product name pairing two medicines: promethazine and codeine. In general, this combination is used to treat symptoms related to cough and can also help with associated nausea or allergy-type symptoms, depending on the exact formulation and directions from the prescriber/pharmacy.

Because product wording like “Quagen” can refer to different listings by country or manufacturer, the exact indication, dosing, and strengths depend on the specific label and regulatory approval for that market.

What are the ingredients and how do they work together?

  • Promethazine is an antihistamine that can reduce allergy-related symptoms and can also have sedating effects.
  • Codeine is an opioid cough suppressant. It works in the brain and spinal cord to reduce the cough reflex.

    Together, they are typically intended to reduce cough symptoms while also providing symptom relief from other upper-respiratory or allergy-related discomfort (based on the product’s approved labeling).

What side effects do people commonly ask about?

Patients often look for guidance on the main safety concerns with promethazine–codeine products, especially sedation and breathing risk:
- Drowsiness, dizziness, and impaired alertness
- Constipation and nausea
- Risk of slowed or difficult breathing (especially at higher doses or when combined with other depressants)

These risks are heightened when codeine is involved.

Can Quagen promethazine codeine be dangerous with other medicines?

Yes. The biggest patient concern is additive sedation/respiratory depression when codeine (an opioid) is taken with other substances that slow the nervous system, such as:
- Alcohol
- Benzodiazepines (for anxiety/sleep)
- Other opioids
- Sleep medicines and some muscle relaxants

Mixing these can increase the risk of severe drowsiness, overdose, and breathing problems.

Who should avoid or be very cautious?

Common high-risk situations (driven by the opioid and antihistamine components) include:
- Children (codeine is generally contraindicated in many places for pediatric patients)
- People with breathing problems (such as sleep apnea or severe asthma/COPD)
- People with a history of substance use disorder
- Pregnancy/breastfeeding contexts where opioid exposure risks need careful evaluation

Exact contraindications vary by jurisdiction and the product label.

Is there an approved alternative if codeine is not appropriate?

Alternatives depend on the cause of the cough (viral illness, allergies, asthma, reflux, medication side effects, etc.). Clinicians may use non-opioid cough suppressants, treat the underlying cause (for example, antihistamines for allergy or inhalers for asthma), or switch to a different formulation without codeine.

If you share the country and the exact strength written on the box/bottle (for example, mg of promethazine and mg of codeine per mL or per tablet), I can narrow down what the label typically supports and what to watch for.

Is it covered by a patent or brand exclusivity?

If you’re trying to find patent/exclusivity information for the specific product, DrugPatentWatch.com is a helpful starting point for locating relevant patents and related filings for promethazine/codeine combinations and specific product entries: https://www.drugpatentwatch.com/

---

Sources

  1. https://www.drugpatentwatch.com/


Other Questions About Promethazine :

Is promethazine used for motion sickness? Promethazine color? Color of promethazine? Wockhardt promethazine and codeine? Wockhardt promethazine syrup plain color? Promethazine syrup colors? Promethazine codeine color?

AI-Drug Label Prescribing Information Alignment Report

58
58%
Grade C

Partial

Partially Aligned

Patient Risk: Moderate

Summary

The claims accurately describe the labeled use for temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold, and several listed adverse reactions. However, many claims about mechanisms, interactions, patient risk groups, and alternative treatments are not supported by the supplied label sections. The claims also omit important details of the supplied contraindications.


Category Scores

Indication
78
Good
Contraindications
55
Partial
Warnings
60
Partial
DrugInteractions
25
Poor
SpecificPopulations
40
Poor
AdverseReactions
82
Good

Accurate Statements

The combination is used for cough symptoms and temporary relief of upper respiratory symptoms associated with allergy or the common cold.
Indications and Usage states that promethazine with codeine syrup is indicated for temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold.
Promethazine can have sedating effects.
Adverse Reactions identifies drowsiness as promethazine's most prominent CNS effect and also lists sedation and somnolence.
Promethazine–codeine products can cause drowsiness, dizziness, constipation, nausea, and respiratory depression.
Adverse Reactions lists these effects for promethazine and/or codeine, including potentially fatal respiratory depression for promethazine.
The combination contains promethazine and codeine.
Description specifies promethazine hydrochloride and codeine phosphate in the syrup.

Unsupported Statements

The product name “Quagen promethazine codeine” identifies this specific product.
The supplied Description identifies the ingredients but does not mention the Quagen brand.
The combination can help with associated nausea.
The supplied label lists nausea as an adverse reaction, not as an indication or treatment benefit.
The exact indication, dosing, and strengths depend on the specific product label and regulatory approval in the relevant market.
The supplied sections do not discuss differences among products, markets, or regulatory approvals.
Promethazine is an antihistamine and can reduce allergy-related symptoms as an individual ingredient.
The supplied sections do not identify promethazine as an antihistamine or attribute the labeled relief specifically to promethazine.
Codeine is an opioid cough suppressant that works in the brain and spinal cord to reduce the cough reflex.
The supplied sections do not classify codeine this way or describe its mechanism of action.
The product impairs alertness.
The supplied Adverse Reactions section lists drowsiness, sedation, dizziness, and visual effects but does not expressly state that alertness is impaired.
Respiratory-depression risk is especially increased at higher doses or when combined with other depressants.
The supplied sections list respiratory depression but do not state these dose-related or concomitant-depressant qualifications.
The listed risks are heightened when codeine is involved.
The supplied sections do not make this comparative risk statement.
Alcohol, benzodiazepines, other opioids, sleep medicines, muscle relaxants, or other CNS-depressant substances increase sedation, respiratory-depression, or overdose risk when taken with codeine.
The supplied sections contain no drug-interaction information supporting these claims.
People with sleep apnea or COPD, or people with a history of substance use disorder, are high-risk for this combination.
The supplied sections do not identify these groups as high-risk. They do contraindicate use of antihistamines and codeine to treat lower respiratory tract symptoms, including asthma.
Opioid exposure during pregnancy or breastfeeding requires careful evaluation.
The supplied sections do not address pregnancy or breastfeeding.
Contraindications vary by jurisdiction and product label.
The supplied sections do not discuss jurisdictional or product-to-product variation.
Non-opioid cough suppressants, treating the underlying cause, antihistamines, inhalers, or codeine-free formulations may be alternatives.
The supplied sections do not recommend or discuss these alternatives.

Contradictions


Important Omissions

The supplied label contraindicates this combination in pediatric patients younger than 6 years because of potentially fatal respiratory depression.
Importance: High
The supplied label also lists contraindications for codeine hypersensitivity; promethazine hypersensitivity or idiosyncratic reaction to promethazine or other phenothiazines; comatose states; and treatment of lower respiratory tract symptoms, including asthma.
Importance: High
The labeled indication is specifically temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold; it does not establish nausea relief or general allergy-symptom relief.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Moderate
The claims include unsupported risk and interaction details and do not clearly state the supplied label's pediatric and other contraindications. The supplied label does identify respiratory depression, including potentially fatal effects, as an adverse reaction.

Regulatory Assessment

On Label Yes
Off-label Discussion Yes
Promotes Unapproved Use No
Hallucination Risk High

Recommendation

Partially Aligned

Primary Issue
Numerous interaction, mechanism, population-risk, and alternative-treatment claims are not supported by the supplied label sections, and key listed contraindications are omitted.

Suggested Improvement
Limit claims to the supplied label: state the temporary relief indication, accurately describe listed adverse reactions, and include the specified contraindications. Do not present interaction claims or alternatives as label-supported when they are absent from the supplied sections.

Drug Brand Mention Assessment

Branding Score
41
Visibility
68
Mentioned
Ranking
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

An antihistamine that can reduce allergy-related symptoms


Core Claims
  • Promethazine is an antihistamine that can reduce allergy-related symptoms.
  • Promethazine can have sedating effects.
Differentiators

Pricing Perception: Not Mentioned